calendar
2,609 catalysts · 4,970 phase readout · 2,331 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
next 91 dayslessmore
MonWedFri
2,609 catalysts · 4,970 phase readout · 2,331 8k filing · 283 earnings · 277 pdufa · 115 phase 2 completion · 53 phase 1 completion
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 3.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.07
Items: 7.01, 9.01
Items: 5.02
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 3.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.03, 5.07, 9.01
Items: 2.02, 9.01
Items: 5.02
Items: 4.02
Items: 5.02
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 3.02, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 9.01
Items: 1.01, 2.03, 3.01, 3.03, 9.01
Items: 2.05, 7.01, 9.01
Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01